You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-BCL3 (BCL3) Antibodies

Full name:
anti-B-Cell CLL/lymphoma 3 Antibodies (BCL3)
On www.antibodies-online.com are 108 B-Cell CLL/lymphoma 3 (BCL3) Antibodies from 20 different suppliers available. Additionally we are shipping BCL3 Kits (33) and BCL3 Proteins (10) and many more products for this protein. A total of 159 BCL3 products are currently listed.
Synonyms:
AI528691, Bcl-3, BCL3, BCL4, D19S37
list all antibodies Gene Name GeneID UniProt
BCL3 12051 Q9Z2F6
BCL3 602 P20749
BCL3 680611  

Show all species

Show all synonyms

Most Popular Reactivities for anti-BCL3 (BCL3) Antibodies

Select your species and application

anti-Mouse (Murine) BCL3 Antibodies:

anti-Human BCL3 Antibodies:

anti-Rat (Rattus) BCL3 Antibodies:

All available anti-BCL3 Antibodies

Go to our pre-filtered search.

Top referenced anti-BCL3 Antibodies

  1. Human Polyclonal BCL3 Primary Antibody for EIA, FACS - ABIN950634 : Kabuta, Hakuno, Cho, Yamanaka, Chida, Asano, Wada, Takahashi: Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity. in Biochemical and biophysical research communications 2010 (PubMed)
    Show all 3 references for ABIN950634

  2. Human Monoclonal BCL3 Primary Antibody for EIA - ABIN950628 : Mitchell, Hildeman, Kedl, Teague, Schaefer, White, Zhu, Kappler, Marrack: Immunological adjuvants promote activated T cell survival via induction of Bcl-3. in Nature immunology 2001 (PubMed)
    Show all 2 references for ABIN950628

  3. Human Monoclonal BCL3 Primary Antibody for FACS - ABIN950630 : Watanabe, Iwamura, Shinoda, Fujita: Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation. in The EMBO journal 1997 (PubMed)
    Show all 2 references for ABIN950630

  4. Human Polyclonal BCL3 Primary Antibody for FACS, IF - ABIN653286 : Folco, Rocha, López-Ilasaca, Libby: Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. in The Journal of biological chemistry 2009 (PubMed)
    Show all 2 references for ABIN653286

More Antibodies against BCL3 Interaction Partners

Mouse (Murine) B-Cell CLL/lymphoma 3 (BCL3) interaction partners

  1. Bcl3 reduces the inflammatory response in pancreas/biliary tissue by blocking ubiquitination and proteasome-mediated degradation of nuclear factor-kappaB p50 (show NFKB1 Antibodies) homodimers.

  2. Low expression of IL-6 (show IL6 Antibodies) and TNF-alpha (show TNF Antibodies) correlates with the presence of the nuclear regulators of NF-kappaB (show NFKB1 Antibodies), IkappaBNS (show NFKBID Antibodies) and BCL-3, in the uterus of mice.

  3. These findings demonstrate that Bcl-3 is required in dendritic cells to prime protective T-cell-mediated immunity to T. gondii

  4. data show that BCL-3 makes extensive contacts with p50 (show LSP1 Antibodies) homodimers and in particular with ankyrin repeats (ANK) 1 (show ANK1 Antibodies), 6, and 7, and the N-terminal region of Bcl-3.

  5. The presence of a p50 (show LSP1 Antibodies)/Bcl-3 complex in nuclear extracts from cells of metastatic lung tissues.

  6. In SOD1 (show SOD1 Antibodies) and Neurotomized mice the results of this studysuggest LC3 (show MAP1LC3A Antibodies), Fn14 (show TNFRSF12A Antibodies), Bcl3 and Gadd45a (show GADD45A Antibodies) as candidate genes involved in the maintenance of the severe atrophic state.

  7. These findings identify Bcl-3 as a critical player during the later stage of the contact hypersensitivity reaction to limit inflammation via actions in radioresistant cells, including keratinocytes.

  8. The results expose a previously unidentified function for Bcl-3 in dendritic cell survival and the generation of adaptive immunity.

  9. Bcl-3 constrained Th1 (show HAND1 Antibodies) cell plasticity and promoted pathogenicity by blocking conversion to Th17-like cells, revealing a unique type of regulation that shapes adaptive immunity.

  10. This study demonstrates that interaction with p50 (show LSP1 Antibodies) is necessary and sufficient for the anti-inflammatory properties of Bcl-3 and further highlights the importance of p50 (show LSP1 Antibodies) homodimer stability in the control of NF-kappaB (show NFKB1 Antibodies) target gene expression.

Human B-Cell CLL/lymphoma 3 (BCL3) interaction partners

  1. Bcl3 reduces the inflammatory response in pancreas/biliary tissue by blocking ubiquitination and proteasome-mediated degradation of nuclear factor-kappaB p50 (show NFKB1 Antibodies) homodimers.

  2. Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients

  3. Subcellular localization of Bcl-3 could be a potential-early diagnostic marker in colon cancer.

  4. Bcl-3 is involved in the development of Tfh cells and the pathogenesis of RA, presumably by inducing IL-21 (show IL17C Antibodies) production.

  5. Suggest the involvement of BCL3 in cardiovascular disease, which could be partly mediated through the influence on metabolic phenotypes.

  6. These findings suggest that the two LMP1 (show PDLIM7 Antibodies) signaling domains modulate their combined activity and that the bcl3 transcription factor is likely responsible for some of the unique effects of CTAR1 domain on cellular expression.

  7. DC-SIGN (show CD209 Antibodies) directs adaptive T helper cell type-2immunity to fucose-expressing pathogens via an IKKepsilon (show IKBKE Antibodies)-CYLD (show CYLD Antibodies)-dependent signalling pathway leading to Bcl3 activation.

  8. data show that BCL-3 makes extensive contacts with p50 (show CD40 Antibodies) homodimers and in particular with ankyrin repeats (ANK) 1 (show ANK1 Antibodies), 6, and 7, and the N-terminal region of Bcl-3.

  9. a delayed (incoherent) feed-forward loop together with differential rates of TNFA (show TNF Antibodies) (fast) and BCL3 (slow) mRNA turnover provide robust, pulsatile expression of TNFalpha (show TNF Antibodies)

  10. Bcl-3 plays a critical role in stabilizing c-Myc (show MYC Antibodies) protein via ERK (show EPHB2 Antibodies) activation.

BCL3 Antigen Profile

Antigen Summary

This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B.

Alternative names and synonyms associated with BCL3

  • B-cell CLL/lymphoma 3 (BCL3) antibody
  • B-cell CLL/lymphoma 3 (LOC100356260) antibody
  • B cell leukemia/lymphoma 3 (Bcl3) antibody
  • B-cell CLL/lymphoma 3 (Bcl3) antibody
  • AI528691 antibody
  • Bcl-3 antibody
  • BCL3 antibody
  • BCL4 antibody
  • D19S37 antibody

Protein level used designations for BCL3

B-cell CLL/lymphoma 3 , B-cell leukemia/lymphoma 3 , B-cell lymphoma 3 protein homolog , B-cell lymphoma 3 protein , B-cell lymphoma 3-encoded protein , BCL-3 , chronic lymphatic leukemia protein , proto-oncogene BCL3

GENE ID SPECIES
713049 Macaca mulatta
744209 Pan troglodytes
100356260 Oryctolagus cuniculus
100597835 Nomascus leucogenys
12051 Mus musculus
602 Homo sapiens
680611 Rattus norvegicus
612349 Canis lupus familiaris
100738193 Sus scrofa
531942 Bos taurus
100718288 Cavia porcellus
101111483 Ovis aries
Selected quality suppliers for anti-BCL3 (BCL3) Antibodies
Did you look for something else?